Director/PDMR Shareholding
Amryt (Nasdaq: AMYT, AIM: AMYT) announced the grant of 3,431,350 share options to CEO Joe Wiley and CFO Rory Nealon, approved by the Remuneration Committee. The exercise price is set at US$2.804 per Share. Options can be exercised in increments over three years, with 25% available after 12 months. All options are subject to change of control provisions and expire seven years post-grant. Following this grant, Wiley holds 8,468,810 options and Nealon holds 6,226,823 options, reflecting their commitment to the company's growth.
- Grant of 3,431,350 share options to key executives, indicating management confidence and alignment with shareholder interests.
- Options are structured to incentivize long-term performance with a vesting schedule.
- None.
Grant of Options and Notification of Transactions by Persons Discharging Managerial Responsibilities
DUBLIN, Ireland, and Boston MA, March 8, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company focussed on acquiring, developing and commercializing novel treatments for rare diseases, today announces that the Remuneration Committee has approved the grant of 3,431,350 share options ("Options") to subscribe for ordinary shares in the Company ("Shares") under the Employee Share Option Plan 2019 (the "Plan") to Joe Wiley, CEO, and Rory Nealon, CFO, details of which are set out in the table below.
The Options have an exercise price of US
| ● | |
| ● | a further |
| ● | the balance of the Options may be exercised 36 months after the date of grant. |
All Options are subject to change of control provisions and expire on the seventh anniversary of their grant.
Following the grants of these options, the following Director and Company Secretary have the following options:
| Director / Company Secretary | Options granted | Total Options now held |
| Joe Wiley | 2,031,350 | 8,468,810 |
| Rory Nealon | 1,400,000 | 6,226,823 |
PDMR Dealings
The notification of dealing forms for each Director/Company Secretary can be found below. This announcement is made in accordance with Article 19 of the EU Market Abuse Regulation 596/2014.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | ||||
| a) | Name | Joe Wiley | |||
| 2. | Reason for the notification | ||||
| a) | Position / status |
{
"@context": "https://schema.org",
"@type": "FAQPage",
"name": "Director/PDMR Shareholding FAQs",
"mainEntity": [
{
"@type": "Question",
"name": "When was the share options grant announced for AMYT?",
"acceptedAnswer": {
"@type": "Answer",
"text": "The share options grant for Amryt was announced on March 8, 2021."
}
},
{
"@type": "Question",
"name": "How many options were granted to the executives at AMYT?",
"acceptedAnswer": {
"@type": "Answer",
"text": "A total of 3,431,350 share options were granted to CEO Joe Wiley and CFO Rory Nealon."
}
},
{
"@type": "Question",
"name": "What is the exercise price for the share options granted by AMYT?",
"acceptedAnswer": {
"@type": "Answer",
"text": "The exercise price for the share options is US$2.804 per share."
}
},
{
"@type": "Question",
"name": "What is the vesting schedule for the options granted at AMYT?",
"acceptedAnswer": {
"@type": "Answer",
"text": "The options may be exercised in increments: 25% after 12 months, 25% after 24 months, and the remaining balance after 36 months."
}
}
]
}
FAQ
When was the share options grant announced for AMYT?
The share options grant for Amryt was announced on March 8, 2021.
How many options were granted to the executives at AMYT?
A total of 3,431,350 share options were granted to CEO Joe Wiley and CFO Rory Nealon.
What is the exercise price for the share options granted by AMYT?
The exercise price for the share options is US$2.804 per share.
What is the vesting schedule for the options granted at AMYT?
The options may be exercised in increments: 25% after 12 months, 25% after 24 months, and the remaining balance after 36 months.
Amryt Pharma Plc
NASDAQ:AMYTAMYT RankingsAMYT Latest NewsAMYT Stock Data | |||